Too right, ipscs are the future and big pharma is realising this. Good on Novo Nordisk for tackling the big diseases - Parkinsons, diabetes and chronic heart failure. Good on Cynata for having the best quality mscs which are ipsc derived, sourced from the same material that Novo Nordisk is now investigating.
CYP Price at posting:
29.5¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)